AT279041B - Process for the inactivation of infectious microorganisms - Google Patents

Process for the inactivation of infectious microorganisms

Info

Publication number
AT279041B
AT279041B AT590668A AT590668A AT279041B AT 279041 B AT279041 B AT 279041B AT 590668 A AT590668 A AT 590668A AT 590668 A AT590668 A AT 590668A AT 279041 B AT279041 B AT 279041B
Authority
AT
Austria
Prior art keywords
inactivation
infectious microorganisms
infectious
microorganisms
Prior art date
Application number
AT590668A
Other languages
German (de)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of AT279041B publication Critical patent/AT279041B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT590668A 1967-06-22 1968-06-20 Process for the inactivation of infectious microorganisms AT279041B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1617350A DE1617350C3 (en) 1967-06-22 1967-06-22 Process for the inactivation of biological material

Publications (1)

Publication Number Publication Date
AT279041B true AT279041B (en) 1970-02-25

Family

ID=6986788

Family Applications (1)

Application Number Title Priority Date Filing Date
AT590668A AT279041B (en) 1967-06-22 1968-06-20 Process for the inactivation of infectious microorganisms

Country Status (9)

Country Link
JP (1) JPS494932B1 (en)
AT (1) AT279041B (en)
BE (1) BE717053A (en)
BR (1) BR6800054D0 (en)
CH (1) CH562612A5 (en)
DE (1) DE1617350C3 (en)
FR (2) FR1588829A (en)
IL (1) IL30206A (en)
LU (1) LU56297A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748132A1 (en) * 1977-10-27 1979-05-03 Behringwerke Ag STABILIZER FOR POLYSACCHARIDE
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
JPS6013718A (en) * 1983-07-05 1985-01-24 Chemo Sero Therapeut Res Inst B-type hepatitis vaccine
JPS6122331U (en) * 1984-07-16 1986-02-08 マルコン電子株式会社 Capacitor for rotating machines
JPS6286707A (en) * 1985-10-02 1987-04-21 アテシ High voltage high energy density capacitor
FR2814957B1 (en) * 2000-10-06 2002-12-20 Aventis Pasteur VACCINE COMPOSITION AND STABILIZATION METHOD

Also Published As

Publication number Publication date
LU56297A1 (en) 1970-01-15
DE1617350B2 (en) 1979-01-11
FR1588829A (en) 1970-03-16
IL30206A0 (en) 1968-08-22
DE1617350A1 (en) 1971-03-25
JPS494932B1 (en) 1974-02-04
DE1617350C3 (en) 1979-09-06
FR8086M (en) 1970-07-20
CH562612A5 (en) 1975-06-13
BE717053A (en) 1968-12-24
IL30206A (en) 1972-05-30
BR6800054D0 (en) 1973-02-13

Similar Documents

Publication Publication Date Title
CH462176A (en) Process for the preparation of 1-aralkyl-4- (thiazolyl-2) -piperazines
CH540977A (en) Device for the cultivation of microorganisms
AT289011B (en) Process for the microbiological production of lipase
AT279041B (en) Process for the inactivation of infectious microorganisms
CH482672A (en) Process for the preparation of benzenesulfonylureas
CH479636A (en) Process for the production of copolymers
CH449043A (en) Process for the production of L-alanine
CH456568A (en) Process for the preparation of benzenesulfonylureas
CH468981A (en) Process for the preparation of benzenesulfonylureas
AT271356B (en) Process for the isolation of microorganisms
CH451111A (en) Process for the preparation of benzenesulfonylureas
AT287194B (en) Process for the production of bacterial fractions
AT272294B (en) Process for the preparation of α, ω-alkylenediamines
CH455741A (en) Process for the preparation of benzenesulfonylureas
AT270199B (en) Process for the production of amorphous copolymers
AT272295B (en) Process for the preparation of α, ω-alkylenediamines
CH451112A (en) Process for the preparation of benzenesulfonylureas
AT282194B (en) Process for the production of copolymers of tioxane
CH449603A (en) Process for the preparation of benzenesulfonylureas
CH469679A (en) Process for the preparation of benzenesulfonylureas
CH481893A (en) Process for the preparation of benzenesulfonylureas
CH470364A (en) Process for the preparation of benzenesulfonylureas
CH498465A (en) Process for the production of magnetogram carriers
CH441764A (en) Process for the production of copolymers
CH468996A (en) Process for the purification of B-lactones

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee